Feature Channels:

Asthma

Add to Favorites Subscribe Share
fbshare-Asthma

Showing results

3140 of 493
Newswise: E-Cigarettes Appear to Reduce Body’s Ability to Fight Flu
  • Embargo expired:
    20-May-2019 3:15 PM EDT

Article ID: 712564

E-Cigarettes Appear to Reduce Body’s Ability to Fight Flu

American Thoracic Society (ATS)

E-cigarettes may diminish the body’s ability to fight viruses, specifically those that cause the flu, according to research presented at ATS 2019.

Released:
13-May-2019 8:00 AM EDT
ScreenShot2016-07-21at10.42.00AM.png

Article ID: 713158

Key Drug Target Shown Assembling in Real-Time

Case Western Reserve University

Over one-third of all FDA-approved drugs act on a specific family of proteins: G-protein coupled receptors (GPCRs). Drugs to treat high blood pressure, asthma, cancer, diabetes and myriad other conditions target GPCRs throughout the body—but a recent study shows what happens next. In results published in Cell, researchers outline the timeline of events, including precisely when and how different parts of a GPCR interacts with its G protein signaling partners. The findings provide new insights into the fundamental mechanisms of drug-induced signaling in cells, including ways to identify the most critical portions of GPCRs for targeting development of novel therapeutics.

Released:
20-May-2019 11:05 AM EDT
Newswise: New Investigational Therapy Shows Promise for Asthma Patients in Phase 2 Trial
  • Embargo expired:
    20-May-2019 10:45 AM EDT

Article ID: 712558

New Investigational Therapy Shows Promise for Asthma Patients in Phase 2 Trial

American Thoracic Society (ATS)

In a Phase 2 trial, RTB101, which belongs to a class of drugs known as TORC1 inhibitors, was observed to be well tolerated and to reduce the incidence of respiratory tract infections in adults age 65 and older when given once daily for 16 weeks during winter cold and flu season

Released:
13-May-2019 8:00 AM EDT
ats-logo.gif
  • Embargo expired:
    20-May-2019 10:15 AM EDT

Article ID: 712490

Long-Term Use of Benralizumab Appears Safe, Effective for Severe Asthma

American Thoracic Society (ATS)

Patients with severe eosinophilic asthma, who participated in three different Phase 3 trials of benralizumab (brand name Fasenra) and then enrolled in a long-term trial of the drug’s efficacy and safety, continued to experience fewer exacerbations and improved pulmonary function and quality of life

Released:
13-May-2019 8:00 AM EDT
Newswise: Enzyme May Represent New Target for Treating Asthma
  • Embargo expired:
    20-May-2019 10:15 AM EDT

Article ID: 712500

Enzyme May Represent New Target for Treating Asthma

American Thoracic Society (ATS)

An enzyme called diacylglycerol kinase zeta (DGKζ) appears to play an important role in suppressing runaway inflammation in asthma and may represent a novel therapeutic target,

Released:
13-May-2019 8:00 AM EDT
Newswise: Cardiac MRI May Lead to Targeted PAH Therapy
  • Embargo expired:
    20-May-2019 10:15 AM EDT

Article ID: 712556

Cardiac MRI May Lead to Targeted PAH Therapy

American Thoracic Society (ATS)

Patients at greatest risk of dying from pulmonary arterial hypertension (PAH) may be identified through cardiac magnetic resonance imaging (MRI) and the information the noninvasive scan provides about the functional level of the heart’s right ventricle, according to research presented at ATS 2019.

Released:
13-May-2019 8:00 AM EDT
Newswise: Bacterial Pneumonia Predicts Ongoing Lung Problems in Infants Hospitalized for Acute Respiratory Failure
  • Embargo expired:
    19-May-2019 10:15 AM EDT

Article ID: 712574

Bacterial Pneumonia Predicts Ongoing Lung Problems in Infants Hospitalized for Acute Respiratory Failure

American Thoracic Society (ATS)

Bacterial pneumonia appears to be linked to ongoing breathing problems in previously healthy infants who were hospitalized in a pediatric intensive care unit for acute respiratory failure, according to research presented at ATS 2019.

Released:
13-May-2019 8:00 AM EDT
  • Embargo expired:
    16-May-2019 12:05 AM EDT

Article ID: 712888

Children Who Use Asthma Tracking App Have Better Disease Control and Fewer Hospital Visits

University of Utah Health

An app that allows parents and doctors to monitor a child’s asthma has a big impact on managing the disease. When families monitored symptoms with eAsthma Tracker and adjusted care accordingly, children had better asthma control and made fewer visits to the emergency department. Using the app also meant that children missed fewer days of school and parents took fewer days off work, improving quality of life.

Released:
15-May-2019 8:00 AM EDT
Newswise: Iceland Volcano Eruption in 1783-84 Did Not Spawn Extreme Heat Wave

Article ID: 712084

Iceland Volcano Eruption in 1783-84 Did Not Spawn Extreme Heat Wave

Rutgers University-New Brunswick

An enormous volcanic eruption on Iceland in 1783-84 did not cause an extreme summer heat wave in Europe. But, as Benjamin Franklin speculated, the eruption triggered an unusually cold winter, according to a Rutgers-led study. The study, in the Journal of Geophysical Research: Atmospheres, will help improve predictions of how the climate will respond to future high-latitude volcanic eruptions.

Released:
15-May-2019 11:00 AM EDT
Newswise: The Forum of International Respiratory Societies Calls on Health Care Providers Worldwide to STOP for Asthma

Article ID: 712464

The Forum of International Respiratory Societies Calls on Health Care Providers Worldwide to STOP for Asthma

American Thoracic Society (ATS)

On World Asthma Day, the American Thoracic Society joins the Global Initiative for Asthma (GINA) and other founding members of the Forum of International Respiratory Societies (FIRS) in recognizing this year’s theme: “STOP for asthma.” FIRS calls on global health care providers to STOP for asthma and evaluate symptoms, test response to therapy, observe and assess, and finally proceed to adjust treatment.

Released:
7-May-2019 9:35 AM EDT

Showing results

3140 of 493

Chat now!